![David L. Bellitt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David L. Bellitt
Nessuna posizione attualmente
Profilo
David L.
Bellitt has been President of Celliance Corporation since November 2004.
He was Vice President of Global Commercial Operations for Celliance Corporation from January 2003 to 2004.
From October 2000 to October 2002, he was Senior Vice President of Aksys, Ltd.
From June 1997 to November 1999, he was Senior Vice President of Akzo Nobel.
He received a BS in biology and chemistry from California State University.
Precedenti posizioni note di David L. Bellitt
Società | Posizione | Fine |
---|---|---|
Celliance Corp.
![]() Celliance Corp. BiotechnologyHealth Technology Celliance Corp. used to develop and manufacture bioprocess products. It also offered bioprocess products and services including contract research, manufacturing services and cell culture media supplements. The company was located in Norcross, GA. | Presidente | - |
Serologicals Corp.
![]() Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Corporate Officer/Principal | - |
Formazione di David L. Bellitt
California State University-Fullerton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Serologicals Corp.
![]() Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Commercial Services |
Celliance Corp.
![]() Celliance Corp. BiotechnologyHealth Technology Celliance Corp. used to develop and manufacture bioprocess products. It also offered bioprocess products and services including contract research, manufacturing services and cell culture media supplements. The company was located in Norcross, GA. | Health Technology |
- Borsa valori
- Insiders
- David L. Bellitt